Cellular Basis for Immunological Tolerance Flashcards

1
Q

What is the result of loss of tolerance to self-antigens?

A

Autoimmune diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a major problem concerning chronic infections and tolerance?

A

Chronic infections can lead to immunological tolerance against the infections agents and therefore recurring infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where is central tolerance developed?

A

In the thymus: T-cells that react too strongly to self-antigens are eliminated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

.How do regulatory T cells play a role in peripheral tolerance?

A

Regulatory T cells are professional T cells that are designed to impose suppression on other T cells and accessory cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are myeloid derived suppressor cells (MDSCs)

A

MDSCs are a group of myeloid cells that become potent immunoregulatory cells when exposed to inflammatory cytokines such as IFN-gamma and kill activated T cells to prevent further stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What happens to T cells that are inappropriately or insufficiently stimulated?

A

They become anergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does AIRE aid the the process of central tolerance?

A

AIRE gene enables thymic stromal cells to express non-thymic genes. It allows for the presentation of self antigen to developing thymocytes. T cells that react too strongly die via apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where are regulatory T cells generated in the thymus?

A

Hassall’s corpuscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Where is AIRE expressed?

A

Primarily in the medulla of the thymus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Where are nTregs generated?

A

nTregs are generated in the thymus and impose suppression of other immune cells (mainly T cells).

Since they are generated in the thymus, their antigen diversity is limited to mostly “self-antigens”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What sorts of environmental factors manipulate iTregs?

A

food, commensal organisms, pathogens and tumors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What two cytokines drive the differentiation of naive T cells into iTregs?

A

TGFbeta and IL2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Presence of what cytokines inhbit the induction of iTregs?

A

inflammatory cytokines, primarily IL6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which vitamins serve as co-factors for the induction of iTregs

A

Vitamin A and D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are Tr1 cells?

A

Tr1 cells produce the immunosuppressive cytokine IL-10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which two cytokines induce the differentiation of Tr1 cells?

A

TGFbeta and IL-27. High levels of IL-10 are also sufficient to produce Tr1 cells.

They are NOT Foxp3

17
Q

WHat is IPEX?

A

Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX): syndrome characterized by systemic autoimmunity, typically beginning in the first year of life. IPEX is cased by loss of dysfunction of FOXp3.

18
Q

What happens to T cells that are presented antigens in the absence of the crucial “second signal” - stimulation from CD28 (ligand is CD80/CD86).

A

They become anergic

19
Q

What is the purpose of CTLA-4?

A

CTLA-4 is expressed by T cells after activation and competes with CD28 for binding to B7 (and has a higher affinity for B7 than CD28).

In the natural sequence of antigen action of T cells, there is progressive increasing production of CTLA-4 as a regulatory mechanism to prevent runaway T cell proliferation

20
Q

What happens to people with deficient CTLA-4?

A

They die in utero, due to lethal autoimmune diseases

21
Q

How do clinicians try to suppress graft vs host disease after bone marrow transplants?

A

Though inhibition of co-stimulation done by using CTLA-4 in a “trans” manner to block T cell activation from the outside.

This is accomplished through the use of man-made biologic modified CTLA-4-Ig, which is now also tested in clinical trials to treat autoimmune disorders